Jun 18, 2020
Worldwide DNA Vaccine Market (2020 to 2022) - Increasing Focus on Genetic Vaccine Development
May 20, 2020
INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models
May 19, 2020
PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology
May 14, 2020
INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo® (cemiplimab) Demonstrates 85% of Newly Diagnosed Glioblastoma Patients Are Alive 12 Months Following Treatment
Apr 30, 2020
INOVIO Expands Manufacturing of COVID-19 DNA Vaccine INO-4800 With New Funding from CEPI
Apr 28, 2020
INOVIO Completes Enrollment in the Phase 1 U.S. Trial of INO-4800 for COVID-19 DNA Vaccine; Interim Results Expected in June
Apr 28, 2020
INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference
Apr 12, 2020
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
Apr 06, 2020
INOVIO Initiates Phase 1 Clinical Trial Of Its COVID-19 Vaccine and Plans First Dose Today
Mar 24, 2020
Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
Mar 17, 2020
PharmaJet Received Multi-Year, Multi-Million Dollar Award to Support Next-Generation Needle-Free Delivery Devices
Mar 11, 2020
Plasmid DNA Manufacturing Market to Reach Valuation US$ 300 Mn by 2026
Jan 29, 2020
VGXI to Manufacture Vaccine Against Novel Coronavirus Under CEPI Funded Collaboration
Dec 30, 2019
Asia-Pacific DNA Vaccines Market 2019-2027 - Surge in New Vaccine Development Drives the Market
Nov 25, 2019
Inovio Pharmaceuticals to Present at the 2019 Piper Jaffray 31st Annual Healthcare Conference
Nov 15, 2019
Inovio Pharmaceuticals to Present at the Stifel 2019 Healthcare Conference
Oct 29, 2019
Inovio Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 12, 2019
Sep 17, 2019
Inovio Receives NIH Funding to Target its dMAb® Technology Against Antimicrobial-Resistant Infection
Sep 03, 2019
DNA Vaccine Markets, 2022
Sep 03, 2019
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences